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Development and homeostasis require stringent spatiotem-
poral control of gene expression patterns that are established, to
a large extent, by combinatorial action of transcription regula-
tory proteins. The bZIP transcription factor NRL (neural retina
leucine zipper) is critical for rod versus cone photoreceptor cell
fate choice during retinal development and acts as a molecular
switch to produce rods from postmitotic precursors. Loss ofNrl
inmouse leads to a cone-only retina, whereas ectopic expression
of Nrl in photoreceptor precursors generates rods. To decipher
the transcriptional regulatory mechanisms upstream of Nrl, we
identified putative cis-control elements in the Nrl promoter/
enhancer regionby examining cross-species sequence conserva-
tion. Using in vivo transfection of promoter-reporter constructs
into themouse retina, we show that a 0.9-kb sequence upstream
of the Nrl transcription initiation site is sufficient to drive
reporter gene expression in photoreceptors.We further define a
0.3-kb sequence including a proximal promoter (clusterA1) and
anenhancer (clusterB) that candirect rod-specific expression in
vivo. Electrophoretic mobility shift assays using mouse retinal
nuclear extracts, in combination with specific antibodies, demon-
strate the binding of retinoid-related orphan nuclear receptor 
(ROR), cone rod homeobox, orthodenticle homolog 2, and cyclic
AMP response element-binding protein to predicted consensus
elementswithin clustersAandB.Our studies demonstrateNrl as a
direct transcriptional target of ROR and suggest that combinato-
rial action ofmultiple regulatory factorsmodulates the expression
ofNrl in developing andmature retina.
Generation of cellular diversity and homeostasis are con-
trolled and fine tuned through regulation of gene expression.
The expression of eukaryotic genes is largely modulated at cis-
sequences of the core promoter and enhancer elements that
bind to transcription initiation complex and trans-acting acti-
vator or repressor proteins (1, 2). In addition, protein-protein
interactions, posttranslational modifications, epigenetic marks
on chromatin, and microRNAs facilitate the expression of tis-
sue or cell type-specific genes (3–5). In developmental regula-
tory networks, spatiotemporal expression of transcription fac-
tors primarily dictates functional specification of distinct cell
types (6, 7).
The vertebrate neural retina, with its in vivo accessibility and
a well defined cell repertoire, serves as an excellent model for
investigating the origin and maintenance of cellular diversity.
The retina consists of six types of neurons and one type of glia.
Rod and cone photoreceptors function as specialized sensory
neurons that are responsible for scotopic and photopic vision,
respectively. Rod photoreceptors are highly vulnerable to
genetic defects and environmental abuse (8) and are needed for
cone cell viability (9). Hence, elucidation of genesis and func-
tional maintenance of rod photoreceptors would permit better
design of strategies for treatment of retinal andmacular degen-
erative diseases.
Distinct retinal cell types originate in a conserved temporal
order from multipotent retinal progenitor cells that undergo
progressive changes in transcriptional states (10). Both extrin-
sic cues and intrinsic factors play critical roles in retinal devel-
opment; however, intrinsic mechanisms largely dictate the
acquisition of cell type specificity (11, 12).MASH1,NEUROD1,
MATH5, and other basic helix-loop-helix transcription factors
bias cells toward specific neuronal fates (13, 14). One of the key
regulatory proteins that guides photoreceptor lineage from ret-
inal progenitor cells is the homeodomain transcription factor
orthodenticle homolog 2 (OTX2)3; its loss results in amacrine-
like cells instead of photoreceptors (15). However, OTX2 is not
sufficient to induce specific photoreceptor cell fate and requires
interaction with other specific regulators (16, 17). BLIMP1, a
zinc finger protein, appears to control the choice between pho-
toreceptor and bipolar cell fate (18, 19). Downstream from
OTX2 (and probably BLIMP1) in photoreceptor transcrip-
tional hierarchy, retinoid-related orphan nuclear receptor 
(ROR) controls appropriate differentiation of both rod and
cone photoreceptors (20, 21). The retina of Rorb/mice con-
tains primitive and nonfunctional cones and no rods (17, 21).
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Cell fate specification and maturation of rod versus cone
photoreceptors are dependent on the expression and activity of
four transcription factors: cone rod homeobox (CRX), thyroid
hormone receptor 2 (TR2), neural retina leucine zipper
(NRL), and nuclear receptor subfamily 2, group E, member 3
(NR2E3) (17). The studies using knock-out mice suggest that
the homeodomain protein CRXdoes not specify photoreceptor
cell fate, yet it critically contributes to photoreceptor-specific
gene activation and homeostasis (22, 23). TR2, together with
ROR and retinoid X receptor , modulates cone differentia-
tion and patterning (24, 25). The key transcriptional regulator
of photoreceptor cell fate choice is NRL (26), a basic motif leu-
cine zipper (bZIP) protein that induces postmitotic precursors
to become rods instead of cones (27). Ablation ofNrl in mouse
leads photoreceptor precursors to acquire a “default” short
wavelength-sensitive opsin-expressing cone (S-cone) state (28,
29). NR2E3 is a direct transcriptional target of NRL (30). The
primary role of NR2E3 is to repress the expression of cone
genes. Loss of NR2E3 results in a retina with enhanced S-cone
function and many hybrid photoreceptors expressing both
S-opsin and rhodopsin (17, 31–33). Together with CRX,
NR2E3, and other transcription factors, NRL activates the rod
differentiation pathway by inducing the expression of rod-spe-
cific genes, including rhodopsin and cGMP-phosphodiesterase
(22, 34–36). Not surprisingly, mutations inNRL are associated
with retinal degenerative diseases (37–40).
Previously we showed that a 2.5-kb genomic sequence,
upstream of the Nrl transcription initiation site, contains four
conserved regions (cluster I–IV) that might controlNrl expres-
sion (41, 42). Transgenic mice expressing GFP under the con-
trol of this sequence selectively express the reporter gene in
developing and mature rod photoreceptors (41). Here, we
report the identification of specific cis-control sequence ele-
ments that are required and sufficient for appropriate Nrl
expression in vivo. Our studies establish ROR as a direct tran-
scriptional regulator of Nrl and implicate CRX, OTX2, and
cyclic AMP response element-binding protein (CREB) in mod-
ulating Nrl expression.
EXPERIMENTAL PROCEDURES
Bioinformatic Analysis—Genomic sequences were analyzed
using the July 2007 (mm9)mouse genome assembly (University
of California Santa Cruz Genome Browser Project, Santa Cruz,
CA) (43). The conserved regions upstream ofNrl transcription
start site were aligned with CLUSTALW (44). The TFsearch
program (45),MultiTF tool, andMulan program (46)were used
to find predicted transcription factor binding sites annotated in
the TRANSFAC database (version 4.0) (47).
Plasmid DNA Constructs and Mutagenesis—Genomic se-
quences upstreamof themouseNrl transcription start sitewere
PCR-amplified and cloned into the pEGFP-N1 vector (Clon-
tech). The SV40 basal promoter driving mCherry-IRES-alka-
line phosphatase was generated by replacing GFP with
mCherry sequence in SV40-GFP-IRES-alkaline phosphatase
plasmid (48). Conserved sequence clusters were cloned into
pEGFP-N1 and SV40-mCherry-IRES-alkaline phosphatase.
Sequences contained in each cluster were as follows: cluster A
(304 to 119; relative to the transcriptional start site), A1
(34 to16), B (938 to657), B with intervening sequence
before A (938 to 305), B1 (938 to 786), B2 (814 to
657), C (2734 to 2458). FLAG-tagged CMV-ROR,
CMV-CRX, and CMV-OTX2 expression constructs were gen-
erated in the pDest-515 vector (Science Applications Interna-
tional Corporation, Frederick,MD). ADNA construct contain-
ing a mutant ROR binding site was generated from a Nrl
conserved region (938 to119) as DNA template by sequen-
tial PCRs using the following forward and reverse primers: 5-
GCTGAAAATGTATGGCACACCCCAGCC-3 and 5-GGC-
TGGGGTGTGCCATACATTTTCAGC-3.
In Vivo Transfection Using Electroporation in Mouse Retina—
Neonatal CD-1 mice (Charles River Laboratories, Wilmington,
MA) were used for in vivo transfection by electroporation, as
described (49), in accordance with guidelines for animal care
and experimentation established by the National Institutes of
Health and approval by National Eye Institute Animal Care
and Use Committee. For co-transfection studies, equimolar
amounts of plasmids were used at a concentration of 2–4
g/l. Injection volume was 0.2 l.
Histology—Harvested retinas were dissected and rinsed in
PBS (pH 7.4) and fixed in 4% paraformaldehyde for 15–30 min
at room temperature. After a brief rinse, retinas were cryopro-
tected for 1 h in 30% sucrose and embedded in OCT (Sakura
Finetek). Cryosections (10–12m)were stained for 6min with
DAPI (1 mg/ml in PBS).
Image Analysis—Confocal photomicrographs were acquired
usingOlympus FluoView FV1000 and Leica SP2 confocal laser-
scanningmicroscopes. GFP andmCherry fluorescence intensi-
ties in cells were measured from maximum intensity projec-
tions (9-m thick) of confocal images of retina sections using
ImageJ software (version 1.45f).
Electrophoretic Mobility Shift Assay (EMSA)—EMSAs were
performed as described (30). Briefly, nuclear extracts (5 g)
from HEK293 cells transfected with CMV-ROR or from
mouse retinas were first incubated with 1 g each of poly(dI-
dC) and salmon sperm DNA at 4 °C. After 15 min, 32P-labeled
oligonucleotide was added, and incubation was continued for
another 10 min. To identify the components in protein-DNA
complexes immunologically, samples were incubated with 1g
of a specific antibody (anti-OTX2, anti-CRX, anti-ROR, anti-
NRL, anti-CREB, anti-c-Fos) or normal immunoglobulin G
(control) for 10 min at 4 °C. The reaction mixtures were elec-
trophoresed using 6–8% polyacrylamide gels at 80 V for 1.5 h
and subjected to autoradiography.
Antibodies—The following antibodies were used: anti-OTX2
polyclonal antibody (Chemicon, Billerica,MA), anti-CRXpoly-
clonal antibody (50), anti-ROR polyclonal antibody (Diag-
enode, Denville, NJ), anti-NRL polyclonal antibody (51), anti-
CREB monoclonal antibody (Cell Signaling Technology,
Danvers, MA), anti c-Fos polyclonal antibody (Calbiochem),
and normal immunoglobulin G (Rockland, Gilbertsville, PA).
RESULTS
Identification of Conserved Sequences Required for Rod Pho-
toreceptor-specific Expression ofNrl inVivo—To investigate cis-
regulatory elements, we analyzed the mouse Nrl genomic
sequence using bioinformatics software. Phylogenetic compar-
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ison of a 4-kb sequence upstream of the transcription start site
ofNrl revealed the presence of three noncoding sequence clus-
ters that were highly conserved in vertebrates (Fig. 1A; desig-
nated as clusters A, B, and C in Fig. 1B). To assess their physi-
ological relevance, we performed in vivo transfection of
promoter-reporter constructs in neonatal mouse retinas by
subretinal DNA injection followed by electroporation (Fig. 1B).
A 2.8-kb sequence (2734 to 119), containing all three con-
served clusters A–C, was sufficient to drive EGFP reporter
expression specifically in the outer nuclear layer (ONL), which
contains photoreceptor cell bodies, in P14 retinas (Fig. 1c).
Another construct with a strong CAG promoter driving
mCherry expression (referred to as CAG-mCherry) was co-
transfected as control for transfection efficiency (Fig. 1, a–c). A
majority of mCherry-positive ONL cells were also EGFP-posi-
tive, and no mCherry-positive cells in the inner nuclear layer
(INL) expressed EGFP. These data showed that the 2.8-kb
sequence was sufficient to drive photoreceptor-specific expres-
sion of Nrl in the retina. Transfection of a deletion construct
containing clusters A and B (938 to119) led to robust EGFP
expression (Fig. 1b), whereas cluster A (304 to 119) alone
induced relatively faint reporter expression (Fig. 1a). As pre-
dicted, cone arrestin immunostaining did not overlap with
transfected EGFP-expressing cells in the ONL (Fig. 1C); hence,
Nrl-promoter sequence (clusters A and B; 938 to 119) is
indeed directing the expression to rods.
FIGURE 1. A, Nrl upstream promoter/enhancer sequence showing three major conserved regions. Conservation diagram of Nrl promoter sequence displays
sequence homology among different vertebrates. B, in vivo dissection of promoter activity of conserved sequence clusters. One ormore clusters of themouse
Nrl promoter sequence were used for generating the reporter constructs. Representative sections from neonatal mouse retina, transfected in vivowith three
differentNrlpromoter lengths304 to119 (a),938 to119 (b), and2734 to119 (c), are shown.C, non-overlapping expression of cone arrestin (CAR)
and EGFP expression driven by the Nrl promoter (938 to 119). Retinas were harvested at P14 for examining the expression of the reporter gene. CAG-
mCherry is used to indicate the transfected cells. Scale bars, 20 m. ONL, outer nuclear layer; GCL, ganglion cell layer; INL, inner nuclear layer.
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Fine Mapping of cis-Regulatory Elements—To refine the cis-
regulatory elements involved in controllingNrl expression fur-
ther, we tested the sequences within the three conserved clus-
ters by in vivo transfection. In these experiments, mCherry
reporter gene expression was controlled by Nrl promoter ele-
ments, and ubiquitin promoter-EGFP construct was used as
control for transfections. The full-length 2.8-kb construct
(2734 to 119) and a construct with clusters A, B, and C
concatenated without any intervening sequence exhibited
robust and photoreceptor-specific mCherry expression (Fig. 2,
A andB, respectively). ThemCherry/EGFP fluorescence ratio
(indicative of promoter strength) was higher for the full-length
construct compared with the concatenated A–C construct
(2734 to 119 construct, ratio  0.89; versus A  B  C,
FIGURE 2. Identification of the sequence elementswithinNrlpromoter/enhancer required for rod-specific expression in vivo.Diagramof the upstream
regionofNrldisplays threemain conserved clusters C, B, andA. Representative sections frommouse retina, transfected in vivowith theubiquitin-GFP construct
(A–H) and Nrl promoter-mCherry (A–H), are shown. Retinas were harvested at P14 for examining the expression of the reporter gene. (A–H) are merged
images. Green, GFP fluorescence; red, mCherry fluorescence; blue, DAPI staining. ub-GFP, ubiquitin-GFP; Nrlp-mCh, Nrl promoter-mCherry. Scale bar, 20 m.
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ratio  0.7  0.05; mean  S.E.; n  3 retinas per construct).
Clusters A  B were also sufficient to drive strong and ONL-
specific expression though somewhat lesser than the full-length
or the A  B  C construct (Fig. 2C; ratio  0.56  0.05).
Transfection with a construct containing A  C, however,
did not show reporter gene expression (Fig. 2D; ratio 
0.04  0.01), indicating that the critical sequences for Nrl
expression are contained within cluster B. Transfection of a
construct containing cluster B and a heterologous SV40
basal promoter resulted in little or no reporter expression
(Fig. 2E; ratio  0.11  0.01). Thus, sequence elements in
both B and A clusters are required for appropriate reporter
expression in vivo.
We then defined the relative importance of different
sequence elements within clusters A and B in directing Nrl
expression in vivo. A 129-bp sequence in 3-region of cluster B
(called B2, 814 to 657) combined with cluster A was suffi-
cient to drive ONL-specific expression (Fig. 2F; ratio 0.57
0.05), whereas the 5-153-bp sequence in cluster B (called B1,
938 to786)was unable per se to inducemCherry expression
(Fig. 2G; ratio 0.07 0.01). A 51-bp sequence within cluster
A (called A1), together with B, induced strong reporter gene
expression in ONL (Fig. 2H; ratio 1.16).
ROR, CRX,OTX2, andCREBBindDirectly toNrl Promoter/
Enhancer Sequence Elements—In silico analysis using the
TRANSFAC database (46) revealed a number of conserved
putative transcription factor binding sites within B2 (transcrip-
tionally active sequence in cluster B) and cluster A (Fig. 3,A and
B, respectively). To identify the involvement of specific tran-
scription factors, we performed EMSA using several different
oligonucleotides spanning the conserved sequence elements
(Fig. 4). Because of the lack of expression of NRL in Rorb/
mouse retina (21), we specifically focused on the oligonucleo-
tide sequence B3 (797 to 764 in Fig. 3A, light gray shaded
box) containing putative ROR, ERR1, T3R, OTX2, CRX,
GATA-1, GATA-3, ATF-3, TAX, CREB, Sp1, AML1-A, and
Ik-2 sites. EMSA demonstrated the binding of proteins in adult
and neonatal (postnatal day (P) 1–P2) retinal extracts to oligo-
nucleotide B3 (Fig. 4A, lanes 2–9, and 11; Fig. 4B, lanes 2–10).
In cluster A, we also identified the binding of retinal proteins to
oligonucleotide A4 (75 to 107; Fig. 3B, dark gray shaded
box) that includes putative binding sites for bZIP transcription
factors AP-1, CREB, and ATF- (Fig. 4D, lanes 2–7; Fig. 4E,
lanes 2–7). The binding of nuclear proteins to these two oligo-
nucleotides was specific in that the addition of increasing
amounts of unlabeled respective oligonucleotide reduced the
EMSA signal, whereas a mutant unlabeled competitor oligonu-
cleotide did not affect the signal intensity.
To identify the transcription factor(s) within protein com-
plexes bound to B3 or A4 cis-sequence elements, we performed
EMSA after the addition of specific antibodies. Addition of
ROR antibody resulted in the disappearance of the specific
DNAprotein complex at B3 observed in both the adult retinal
nuclear extract and extract fromHEK293 cells transfected with
aROR expression construct (Fig. 4A, lanes 9 and 10). A similar
dramatic suppression of binding at B3 was observed with neo-
natal retinal extracts when ROR antibody was added (Fig. 4B,
lane 9). Addition of CREB antibody resulted in slight reduction
of B3 EMSA signal with both adult and neonatal retinal extracts
(Fig. 4, A and B, lanes 8). OTX2 and CRX antibodies (Fig. 4A
and B, lanes 6 and 7) did not alter the mobility of B3 oligonu-
cleotide. Because OTX2 and CRX are predicted to be upstream
of NRL in the transcriptional hierarchy during retinal develop-
ment (15, 17), we designed a longer oligonucleotide (B4, from
FIGURE 3. Nrl promoter/enhancer sequence showing predicted sites for trans-acting regulators. The conserved regions909 to667 (A) and117 to
137 (B) in the Nrl promoter were aligned to syntenic sequences from human, orangutan, dog, and rat genomes. * indicates the conserved nucleotides.
Sequences for putative transcription factors binding sites are boxed. The gray shades correspond to oligonucleotide sequences used for EMSA. Light gray box,
A, showspredictedoverlapping sites formany transcription factors including retinoid receptors, homeodomainproteins, ATF-3, CREB, andSp1.Dark gray box,
B, includes putative binding sites for AP-1, CREB, andATF-. The sequenceboxedbydashed lines represents the extensionof oligonucleotide B3 (shown in light
gray) in oligonucleotide B4.
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814 to763 containing 18 additional nucleotides at 5-end of
B3) for EMSA. Interestingly, a gel shift (indicated by an arrow in
Fig. 4C) of B4, obtained by adding nuclear extracts from
HEK293 cells transfected with CRX or OTX2 expression con-
structs, diminished by including CRX or OTX2 antibody,
respectively (Fig. 4C, lanes 5 and 11). Addition of normal con-
trol immunoglobulins (IgG) (Fig. 4A, lanes 11 and 12; Fig. 4B,
lane 10; Fig. 4C, lanes 6 and 12) did not affect themobility of B3
or B4 DNAprotein complex.
With oligonucleotideA4, addition of CREB antibody to adult
or neonatal nuclear extracts showed a supershift of the EMSA
band (Fig. 4,D and E, lanes 4). Antibodies against the two other
bZIP proteins, NRL and c-Fos, and normal IgG did not alter the
mobility (Fig. 4, D and E, lanes 5–7).
Mutations in ROR Binding Site in Nrl Promoter/Enhancer
Abolish Reporter Gene Expression—To assess further the regu-
latory function of ROR on the Nrl promoter, we performed
site-directed mutagenesis by substituting two nucleotides in
the consensus coremotif of the ROR response element (RORE),
AAAATGTAGGTCA, present inNrl cluster B (783 to771).
Whereas the wild-type construct (containing Nrl promoter
sequence 938 to 119; see Fig. 1B) showed strong mCherry
expression in the ONL of P14 retina (Fig. 5A, ratio 0.56), the
mutant construct (carryingmutations in RORE) did not display
any reporter gene expression (Fig. 5B, ratio 0.1 0.01). Our
data therefore establish the importance of RORE (present in
cluster B) and ROR in directly activating the expression ofNrl
in developing retina.
DISCUSSION
Photoreceptors are highly specialized neurons that initiate
visual transduction (52, 53); their death or deterioration is a
major cause of untreatable vision loss (54). Because NRL is crit-
ical for determining rod versus cone cell fate choice (17), iden-
tification of transcription factors that induce its expression
would assist in elucidation of regulatory networks that specify
distinct retinal cell types. In this report, we have defined cis-
control elements responsible for rod-specificNrl expression by
in vivo transfection methods and identified two conserved
upstream sequences (cluster B, 939 to 657 and cluster A,
304 to 119) that, when combined, are sufficient to drive
reporter gene expression in the rod photoreceptors in vivo.
The cluster A sequence includes the transcription start site,
CAAT andGC boxes, and a TATA-like sequence; this cluster is
likely required for the binding of transcription initiation com-
plex. The fact that a basal SV40 promoter did not show any
activity when combined with cluster B in vivo suggests that the
cluster A sequence appears necessary for photoreceptor-spe-
cific expression ofNrl. We further showed that the35 to16
sequence harboring only the GC box and TATA-like element
was sufficient for rod specificity when linked to cluster B. In
addition, the conserved B2 sequence between814 and657
could induce highly specific ONL expression. Within this B2
sequence, a 31-bp element (B3, from 797 to 764), was
highly conserved and had a large predictive score for the
binding of several transcription factors. EMSA studies con-
firmed the binding of retinal proteins, including ROR, to
the B3 sequence.
We unambiguously show a direct role of ROR in mediating
Nrl promoter activity. ROR2, a retina-specific isoform of
ROR (55), plays a key role in the differentiation of both rod
and cone photoreceptors. Early expression of ROR during ini-
tial stages of photoreceptor development is needed to induce a
photoreceptor precursor to become amature rod (21).Rorb/
mice lack rods, overproduce immature S-cones, and exhibit
the loss of Nrl expression, suggesting that ROR acts
upstream of NRL to promote the rod photoreceptor cell fate
FIGURE 4. ROR, CRX, OTX2, and CREB bind to Nrl promoter/enhancer
sequence elements. Autoradiograms of EMSA using nuclear extracts from
adult (A and D) and neonatal P1–2 (B and E) mouse retina and from HEK293
cells transfectedwith CMV-ROR (A, lanes 10 and 12), CMV-CRX or CMV-OTX2
(C) are shown. Addition of 25 or 100 ngof unlabeled specific oligonucleotides
reduced the binding (A and B, lanes 3 and 4; D and E, lane 3), whereas unla-
beledmutant (m) oligonucleotides (A and B, lanes 5) did not compete for the
boundproteins. Oligonucleotide supershift assayswere performedwith anti-
bodies against OTX2, CRX, CREB, ROR, and normal IgG (A and B), with CRX
and OTX2 antibodies (C), and with antibodies against CREB, NRL, c-Fos, and
normal IgG (D and E). B3, B4 and A4 oligonucleotides are indicated below
the appropriate EMSA. The mutant oligonucleotide for B3 included five
substitutions in conserved binding sites. B4 contains 18 additional nucle-
otides at the 5-end of B3 with better core binding sequence(s) for home-
odomain proteins.
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(21). The specific binding of ROR to Nrl promoter in both
developing (P1–2) and adult retina indicates that ROR,
with other trans-acting regulators, helps to initiate the rod
differentiation program and might later maintain Nrl
expression in mature retina.
DNA-binding proteins bind to sequence elements at multi-
ple sites within the genome, and their contribution to specific
gene regulation generally depends on co-operativity and/or
interaction with other regulatory factors to assemble an enhan-
ceosome complex (56, 57). The homeodomain proteins, OTX2
and CRX, are major regulators of photoreceptor development
(15, 17, 23) and hence excellent candidates for modulating Nrl
expression. The putative target binding sites for these factors
are present in the Nrl control element B2 (Fig. 3A). Although
only a slight reduction in B3 gel shift signal is observed with
CRX antibody when added to the neonatal retinal nuclear
extract, a direct binding of CRX and OTX2 to core homeodo-
main binding sequences within B4 (that includes 18 additional
nucleotides 5 of B3) was clearly evident when transfected cell
nuclear extracts were used (Fig. 4C). Because homeodomain
proteins can bind promiscuously to A-T-rich sequence ele-
ments (56, 58), the specificity in gene regulation is likely accom-
plished by their interaction with other proteins. Further inves-
tigations are necessary to identify the role of CRX and/orOTX2
in directly controlling Nrl expression in early stages of photo-
receptor development.
CREB mediates the effects of numerous signaling path-
ways during neuronal development and homeostasis (59).
Notably, deregulation of cAMP in retinal degeneration
mouse models (rd1, rd2, and certain rhodopsin mutants)
leads to insufficient or excessive levels of cAMP and coin-
cides with cell death (60–62). We show that CREB can bind
to both B3 and A4 sequence elements in Nrl promoter/en-
hancer although binding characteristics may be different as
reflected by the effect of anti-CREB antibody in EMSA.
Although CREB has not been specifically associated with
retinal or photoreceptor development, it may integrate spa-
tiotemporal signals during rod differentiation and/or home-
ostasis via its action on Nrl, which may then fine tune the
transcription of specific rod genes.
Expression and binding of distinct trans-acting regulators may
be required fordevelopmental expression versushomeostasis (17).
In this study, we investigated differential regulation of Nrl using
retinal extracts from two stages: P1–P2, at the time of peak rod
birth when Nrl expression is needed to determine the rod fate in
photoreceptor precursors; and adult, when NRL regulates the
expression of rod-specific genes for functionalmaintenance. How
docellsdetermine theappropriate timeor levelsofNrlexpression?
Here we focused on defining the cis-control elements in the Nrl
promoter/enhancer region. Another approachwould be to exam-
ine posttranslational modifications, such as phosphorylation and
SUMOylation, of transcription factors that controlNrl regulation.
Control ofNrl expression may also depend on extrinsic signaling
factors. Notably, FGF and retinoic acid have been implicated in
inducingNrlexpression (42, 63). IdentificationofRORas adirect
transcriptional activator ofNrl andpotential involvement ofCRX,
OTX2, and CREB are consistent with combinatorial and cooper-
ative regulation by intrinsic and extrinsic mechanisms. Our stud-
ies thusprovidenew insights into transcriptional controlpathways
and suggest how retinal progenitor cells can be directed to adopt a
photoreceptor-specific identity.
Much progress has been made toward the treatment of retinal
diseases using adeno-associated virus as a vector for gene therapy
(64–66). As rod photoreceptors degenerate first in many retinal
neurodegenerative diseases, it would be ideal to specifically target
the therapy to rods by using cell-type specific promoters. Because
adeno-associated virus vector can only accommodate a limited
size, one critical factor in promoter choice is the length of the
promoter sequence. Another factor is the promoter strength for
transcriptional activation of the target gene as too high or too low
expression canbe counterproductive. The identification of a small
Nrl promoter/enhancer sequence of0.3 kb that can specifically
direct the target gene to both developing and mature rod photo-
receptors should be of interest in the design of adeno-associated
virus-based therapies for retinal diseases.
Acknowledgments—We are grateful to Douglas Forrest, Tiziana
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FIGURE 5.Mutations in ROR binding site abolish Nrl promoter activity. Representative sections from neonatal mouse retina transfected in vivowith the
ubiquitin (Ub)-GFP construct (left panels) andNrlpromoter segment938 to119wild type (upper center) andmutant for the RORbinding site (lower center,
ROR site located from783 to771) are shown. Retinas were harvested at P14 for examining the expression of the reporter gene. Right panels showmerged
images. Green, GFP fluorescence; red, mCherry fluorescence; blue, DAPI staining. Scale bar, 20 m.
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